Share on StockTwits

Shire PLC (LON:SHP)‘s stock had its “buy” rating reaffirmed by analysts at Jefferies Group in a research report issued to clients and investors on Friday. They currently have a GBX 4,045 ($68.66) price objective on the stock. Jefferies Group’s price objective suggests a potential upside of 8.21% from the stock’s previous close.

A number of other analysts have also recently weighed in on SHP. Analysts at Panmure Gordon raised their price target on shares of Shire PLC from GBX 3,800 ($64.51) to GBX 4,626 ($78.53) in a research note on Friday. They now have a “buy” rating on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Shire PLC in a research note on Tuesday. They now have a GBX 3,500 ($59.41) price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of Shire PLC from GBX 3,920 ($66.54) to GBX 4,350 ($73.84) in a research note on Tuesday, June 10th. They now have a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of GBX 2,971.66 ($50.44).

Shares of Shire PLC (LON:SHP) opened at 4138.00 on Friday. Shire PLC has a 52 week low of GBX 1978.0001 and a 52 week high of GBX 4248.7998. The stock has a 50-day moving average of GBX 3451.12 and a 200-day moving average of GBX 3128.58. The company’s market cap is £24.178 billion.

Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.